Life Cycle Assessment of Functional Food: Improving Sustainability in the Biotechnology Industry through Transparency

With the advancement of biotechnology, consumers are demanding more scientifically advanced products as well as being more concerned with the environmental impact of products. A life cycle carbon footprint assessment is an important tool in reaching net-zero carbon production goals. This paper presents the greenhouse gas emissions of functional foods by highlighting TCI Co., Ltd. as a case study. TCI conducted life cycle assessments (LCAs) on two mainstream products that utilize common manufacturing processes to examine their carbon footprint and gain a better understanding of their environmental impact. The main finding shows that while the manufacturing stage accounts for around 20–30% of emissions, the raw material stage accounts for 70–80% for both products. This suggests that TCI needs to work closely with its suppliers to ensure a low emissions supply chain and to achieve its net-zero target. Not only do these LCAs allow TCI to increase the products’ transparency, but they can also be offered as a reference to other businesses producing similar products. Sharing of knowledge and practices in the biotechnology industry benefits the entire ecosystem and improves corporate sustainability.

Riding the Biotechnology Wave: A Mixed-Methods Analysis of Malaysia's Emerging Biotechnology Industry

<p>Building a sustainable bioeconomy requires strategic alliances, intellectual property,funding and talent. The research focus of this empirical study was to assess Malaysian biotechnology companies regarding their opinions on priorities and capabilities necessary to establish a thriving bioeconomy. The research questions that form the basis of this paper explore the extent to which initial factor endowments affect the trajectory of biotechnology industry development and how Malaysia should prioritise, mobilise and coordinate resources to build a bioeconomy. A mixed methods approach using qualitative interviews and case studies, as well as a quantitative survey, indicated that respondents advocated a resource-based-view in terms of resource allocation and agglomeration towards building Malaysia's bioecnomy. That is, there was strong support to leverage Malaysia's existing capabilities in agriculture and biofuels to derive value-added products towards gaining leadership positions in these respective biotechnology sectors globally. Access to funding and talent emerged as the highest priority capabilities necessary for commercialising discoveries, conducting research and development and accelerating innovation. Respondents perceived the government as having a 'very important' role in building and accelerating the Malaysian biotechnology industry. The gap between required capabilities and strategic priorities provides a framework within which the government may play a central role in coordinate, accelerating and resourcing Malaysia's nascent bioeconomy.</p>

Riding the Biotechnology Wave: A Mixed-Methods Analysis of Malaysia's Emerging Biotechnology Industry

<p>Building a sustainable bioeconomy requires strategic alliances, intellectual property,funding and talent. The research focus of this empirical study was to assess Malaysian biotechnology companies regarding their opinions on priorities and capabilities necessary to establish a thriving bioeconomy. The research questions that form the basis of this paper explore the extent to which initial factor endowments affect the trajectory of biotechnology industry development and how Malaysia should prioritise, mobilise and coordinate resources to build a bioeconomy. A mixed methods approach using qualitative interviews and case studies, as well as a quantitative survey, indicated that respondents advocated a resource-based-view in terms of resource allocation and agglomeration towards building Malaysia's bioecnomy. That is, there was strong support to leverage Malaysia's existing capabilities in agriculture and biofuels to derive value-added products towards gaining leadership positions in these respective biotechnology sectors globally. Access to funding and talent emerged as the highest priority capabilities necessary for commercialising discoveries, conducting research and development and accelerating innovation. Respondents perceived the government as having a 'very important' role in building and accelerating the Malaysian biotechnology industry. The gap between required capabilities and strategic priorities provides a framework within which the government may play a central role in coordinate, accelerating and resourcing Malaysia's nascent bioeconomy.</p>